Statin Protection Against Influenza and COPD Mortality
Overview
Authors
Affiliations
Commentary: Statins, COVID-19, and coronary artery disease: killing two birds with one stone.
Ganjali S, Bianconi V, Penson P, Pirro M, Banach M, Watts G Metabolism. 2020; 113:154375.
PMID: 32976855 PMC: 7511211. DOI: 10.1016/j.metabol.2020.154375.
Epidemiology and Immune Pathogenesis of Viral Sepsis.
Lin G, McGinley J, Drysdale S, Pollard A Front Immunol. 2018; 9:2147.
PMID: 30319615 PMC: 6170629. DOI: 10.3389/fimmu.2018.02147.
Impact of statins and ACE inhibitors on mortality after COPD exacerbations.
Mortensen E, Copeland L, Pugh M, Restrepo M, Malo de Molina R, Nakashima B Respir Res. 2009; 10:45.
PMID: 19493329 PMC: 2697974. DOI: 10.1186/1465-9921-10-45.
Pandemic and seasonal influenza: therapeutic challenges.
Memoli M, Morens D, Taubenberger J Drug Discov Today. 2008; 13(13-14):590-5.
PMID: 18598914 PMC: 2556034. DOI: 10.1016/j.drudis.2008.03.024.